MVI, Sanaria explore new approaches to malaria vaccine

11/4/2009 | Thaindian News

The PATH Malaria Vaccine Initiative has teamed up with Sanaria to develop an experimental malaria vaccine that will use a weakened form of the Plasmodium falciparum parasite. The vaccine currently is in human trials in the U.S. Other vaccine approaches being considered by the researchers include preventing the transmission of the disease from mosquitoes to humans.

View Full Article in:

Thaindian News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA